01.

Executive Profile

Dr.Olusola Idowu is a visionary leader and entrepreneur at the forefront of AI-driven innovation in the cosmetics and pharmaceutical industries. With a unique blend of deep scientific expertise and strategic business acumen, he has consistently delivered groundbreaking technologies and products that redefine industry standards. His work bridges the gap between complex systems science and practical commercial applications, leading to significant advancements in personalised skincare and targeted drug discovery.

02.

Current Role & Company

  • Leading a team of scientists in disrupting the cosmetics and personal care sectors through AI-powered product development.
  • Driving commercial ventures and strategic partnerships within the pharmaceutical and personal care sectors

03.

Key Achievements & Leadership Impact

Pioneering AI in Cosmetics R&D

  • Developed and commercialized a unique AI-driven platform that predicts the efficacy of cosmetic ingredients, significantly reducing R&D costs and time-to-market. This innovation has positioned HexisLab as a leader in personalized skincare solutions.
  • Secured innovation funding and investment more than £1.2m demonstrating the commercial viability and potential of AI in the cosmetics sector.
  • Advancements in P harmaceutical Drug Discovery

  • At e-Therapeutics PLC, played a pivotal role in developing a novel drug discovery IT platform that attracted £40 million in external funding.
  • Led the discovery of seven repositioned drug candidates in two years, with one candidate, Dexanabinol, advancing to late-stage oncology clinical trials.
  • Applied complex systems analysis to identify synergistic intervention points in integrated interactomes and develop clinically validated multi-target drugs with polypharmacology.
  • Driving Innovation through Strategic Leadership

  • Successfully led Board-level discussions to establish strategic objectives and operational plans, ensuring regulatory compliance and fostering productive stakeholder relationships.
  • Secured funding through prestigious grants, including Innovate UK and EPSRC Impact Accelerator Account, to advance AI-driven research in Senolytic and Senostatic compounds.
  • 04.

    Industry Influence & Speaking Engagements, Media Features

    • Invited speaker at international events, including the Leader’s Summit, addressing heads of state and industry leaders on the role of technology in development.
    • Advisor for postgraduate programs at Newcastle University and Teesside University, focusing on the application of big data and AI in healthcare.
    • Published extensively in leading scientific journals, contributing to the advancementof knowledge in personalised skincare, drug discovery and complex systems analysis.
    • Organised and implemented the annual Celebrating Diversity in Science event, promoting inclusivity in the scientific community.
    • Dr. Idowu’s research has been widely recognised, with a significant number of citations in academic literature. Google Scholar

    05.

    Vision & Thought Leadership

    • Dr. Idowu envisions a future where AI transforms the cosmetics and pharmaceutical industries, enabling the development of highly personalised and effective products.
    • He is a strong advocate for the ethical and sustainable use of AI, emphasising its potential to improve customer and patient outcomes while minimising environmental impact.
    • His work is based on the idea of using complex system analysis to understand the interaction of different components in both biological and chemical systems and then using that knowledge to develop new products and therapies.

    06.

    Early Career

  • PhD in Applied Mathematics from Newcastle University. (1997 - 2000)
  • Postdoctoral research fellowships at Stanford University, NASA Ames Research Centre and Newcastle University. (2000 – 2005)
  • 07.

    Voluntary Work

    Gateshead Health NHS Foundation Trust

    Trust Governor (2008-2010)

    Established in 2005, Gateshead is one of the UK’s first NHS Foundation Trusts, employing around 4200 staff and providing 600 beds in addition to community/outreach healthcare services in partnership with other organisations.

    As elected Trust Governor represented the public voice in the delivery of NHS services in the Gateshead area. The role involved scrutinising the performance of the Trust and the Management Team; providing input into the Trust strategy; implementation of national strategy and regulatory compliance frameworks; reviewing Directors’ renumeration, annual budgets and financial accounts.

    08.

    Awards & Recognition

    Layla & Kays – Award: Recognized for excellence at the Pure Beauty Awards UK 2024, highlighting the impact of his innovations in the beauty industry. Link

    2024 Entrepreneurial Award: Receiving recognition from the Entrepreneurs forum. Link

    BTA Award Nomination – AI Champion of the year award Link

    BTA Award Nomination – Entrepreneur of the Year Link

    Presentation at the United Kingdom House of Lords: Shared expertise on Afro-textured hair at a Parliament roundtable, demonstrating influence in addressing specific skincare needs. Link

    Media Features: Featured in TechRound as “Startup of the Week,” highlighting HexisLab’s innovative approach. Link

    Netimes Magazine Interview: Featured in NETimes magazine interview. Link

    House Commons: Science, Innovation and Technology Committee Link

     

    Want to work together?